Precigen Financial Ratios
NASDAQ: PGENHealth CareBiotechnology: Pharmaceutical PreparationsUSD
7.81+0.21 (+2.76%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Precigen ratio analysis
Precigen earned a net margin of -2588.2% in FY 2025, up from -3216.2% a year earlier. Return on equity reached -1198.6%, meaning Precigen generated -11.99 dollars of profit for every dollar of shareholders' equity. Debt-to-equity stood at 4.46 versus 0.00 the year before, and the current ratio was 3.09.
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Precigen financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | — | — | 10.86 | — | — | — | — | — | — |
| Price / sales | 138.33 | 81.85 | 52.64 | 11.32 | 51.43 | 53.27 | 10.11 | 6.22 | 5.98 | 14.88 |
| Price / book | 64.06 | 8.34 | 2.77 | 2.41 | 6.83 | 25.37 | 12.79 | 2.59 | 2.59 | 5.07 |
| Gross margin | — | — | — | — | — | — | — | — | 85.6% | 80.2% |
| Operating margin | -1,141.1% | -3,440.2% | -1,602.5% | — | — | — | — | -334.4% | -59.7% | -65.6% |
| Net margin | -2,588.2% | -3,216.2% | -1,540.6% | 105.2% | -646.0% | -533.0% | -355.3% | -336.9% | -50.7% | -97.7% |
| Free cash flow margin | -927.6% | -1,955.6% | -1,099.9% | -260.0% | -441.7% | -264.3% | -191.6% | -109.7% | -65.1% | -42.2% |
| Return on equity (ROE) | -1,198.6% | -327.8% | -80.9% | 22.4% | -85.9% | -253.8% | -449.5% | -140.4% | -21.9% | -33.3% |
| Return on assets (ROA) | -161.2% | -86.9% | -63.5% | 13.1% | -25.6% | -54.2% | -70.7% | -71.1% | -13.8% | -19.7% |
| Debt / equity | 4.46 | 0.00 | 0.00 | 0.68 | 1.68 | 2.56 | 3.04 | 0.58 | 0.02 | 0.01 |
| Current ratio | 3.09 | 4.76 | 2.99 | 1.50 | 4.52 | 3.54 | 1.91 | 4.64 | 1.92 | 3.33 |
| Revenue growth | 146.7% | -36.9% | -76.9% | 88.6% | -55.4% | -64.7% | -40.0% | -34.5% | 21.0% | 10.0% |
| EPS growth | — | — | -378.6% | — | — | — | — | — | — | — |